SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Quantifying patient- and hospital-level antimicrobial resistance dynamics in Staphylococcus aureus from routinely collected data.

Leclerc, Q; Clements, A; Dunn, H; Hatcher, J; Lindsay, JA; Grandjean, L; Knight, GM (2023) Quantifying patient- and hospital-level antimicrobial resistance dynamics in Staphylococcus aureus from routinely collected data. J Med Microbiol, 72 (7). ISSN 1473-5644 https://doi.org/10.1099/jmm.0.001724
SGUL Authors: Lindsay, Jodi Anne

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (5MB) | Preview

Abstract

Introduction. Antimicrobial resistance (AMR) to all antibiotic classes has been found in the pathogen Staphylococcus aureus. The reported prevalence of these resistances varies, driven by within-host AMR evolution at the patient level, and between-host transmission at the hospital level. Without dense longitudinal sampling, pragmatic analysis of AMR dynamics at multiple levels using routine surveillance data is essential to inform control measures.Gap Statement. The value and limitations of routinely collected hospital data to gain insight into AMR dynamics at the hospital and individual levels simultaneously are unclear.Methodology. We explored S. aureus AMR diversity in 70 000 isolates from a UK paediatric hospital between 2000-2021, using electronic datasets containing multiple routinely collected isolates per patient with phenotypic antibiograms and information on hospitalization and antibiotic consumption.Results. At the hospital level, the proportion of isolates that were meticillin-resistant (MRSA) increased between 2014-2020 from 25-50 %, before sharply decreasing to 30%, likely due to a change in inpatient demographics. Temporal trends in the proportion of isolates resistant to different antibiotics were often correlated in MRSA, but independent in meticillin-susceptible S. aureus. Ciprofloxacin resistance in MRSA decreased from 70-40 % of tested isolates between 2007-2020, likely linked to a national policy to reduce fluoroquinolone usage in 2007. At the patient level, we identified frequent AMR diversity, with 4 % of patients ever positive for S. aureus simultaneously carrying, at some point, multiple isolates with different resistances. We detected changes over time in AMR diversity in 3 % of patients ever positive for S. aureus. These changes equally represented gain and loss of resistance.Conclusion. Within this routinely collected dataset, we found that 65 % of changes in resistance within a patient's S. aureus population could not be explained by antibiotic exposure or between-patient transmission of bacteria, suggesting that within-host evolution via frequent gain and loss of AMR genes may be responsible for these changing AMR profiles. Our study highlights the value of exploring existing routine surveillance data to determine underlying mechanisms of AMR. These insights may substantially improve our understanding of the importance of antibiotic exposure variation, and the success of single S. aureus clones.

Item Type: Article
Additional Information: © 2023 The Authors This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Keywords: S. aureus, diversity, hospital data, resistance dynamics, Child, Humans, Anti-Bacterial Agents, Staphylococcus aureus, Methicillin, Routinely Collected Health Data, Drug Resistance, Bacterial, Staphylococcal Infections, Hospitals, Pediatric, Humans, Staphylococcus aureus, Staphylococcal Infections, Methicillin, Anti-Bacterial Agents, Drug Resistance, Bacterial, Child, Hospitals, Pediatric, Routinely Collected Health Data, 06 Biological Sciences, 07 Agricultural and Veterinary Sciences, 11 Medical and Health Sciences, Microbiology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: J Med Microbiol
ISSN: 1473-5644
Language: eng
Dates:
DateEvent
11 July 2023Published
12 June 2023Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
MR/P014658/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
1R01AI146338National Institute of Allergy and Infectious Diseaseshttp://dx.doi.org/10.13039/100000060
226007/Z/22/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
MR/N013638/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/N013638/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
PubMed ID: 37431889
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115560
Publisher's version: https://doi.org/10.1099/jmm.0.001724

Actions (login required)

Edit Item Edit Item